Clinical trial
Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or…
NCT00470249 · University of Southampton, Other · Terminated
Key facts
| NCT number | NCT00470249 |
|---|---|
| Title | Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer |
| Official title | A Phase II Study of Carboplatin in Combination With Gemcitabine as a Dose Dense Schedule in Patients With Locally Advanced or Metastatic Breast Cancer That Are Resistant to Anthracyclines & Taxanes |
| Lead sponsor | University of Southampton, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Carboplatin, Gemcitabine Hydrochloride |
| Enrollment | 5 |
| Start date | Jul 15, 2006 |
| Primary completion | Nov 3, 2008 |
| Completion | Nov 3, 2008 |
| First posted | May 7, 2007 |
| Last update posted | Feb 1, 2021 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: